Neuroligin 1 modulates striatal glutamatergic neurotransmission in a pathway and NMDAR subunit-specific manner.
Together with its presynaptic partner Neurexin 1 (Nxn1), Neuroligin 1 (NL1) participates in synapse specification and synapse maintenance. We and others have shown that NL1 can also modulate glutamatergic synaptic function in the central nervous system of rodent models. These molecular/cellular changes can translate into altered animal behaviors that are thought to be analogous to symptomatology of neuropsychiatric disorders. For example, in dorsal striatum of NL1 deletion mice, we previously reported that the ratio N-methyl-D-aspartate receptor (NMDAR) mediated synaptic currents to α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor (AMPAR) mediated synaptic currents (NMDA/AMPA) is reduced in medium spiny neuron (MSNs). Importantly, this reduction in NMDA/AMPA ratio correlated with increased repetitive grooming. The striatum is the input nucleus of the basal ganglia (BG). Classical models of this circuitry imply that there are two principal pathways that render distinct and somewhat opposite striatal outputs critical to the function of these nuclei in modulating motor behavior. Thus, we set out to better characterize the effects of NL1 deletion on direct and indirect pathways of the dorsal striatum by genetically labeling MSNs participating in the direct and indirect pathways. We demonstrate that a decrease in NMDAR-mediated currents is limited to MSNs of the direct pathway. Furthermore, the decrease in NMDAR-mediated currents is largely due to a reduction in function of NMDARs containing the GluN2A subunit. In contrast, indirect pathway MSNs in NL1 knockout (KO) mice showed a reduction in the frequency of miniature excitatory neurotransmission not observed in the direct pathway. Thus, NL1 deletion differentially affects direct and indirect pathway MSNs in dorsal striatum. These findings have potential implications for striatal function in NL1 KO mice.
Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center Dallas, TX, USA.
Felipe
F
Espinosa
Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center Dallas, TX, USA.
Zhong
Z
Xuan
Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center Dallas, TX, USA.
Shunan
S
Liu
Department of Neurology and Neurotherapeutics, The University of Texas Southwestern Medical Center Dallas, TX, USA ; Neuroscience Graduate Program, The University of Texas Southwestern Medical Center Dallas, TX, USA ; Department of Psychiatry, The University of Texas Southwestern Medical Center Dallas, TX, USA.
Craig M
CM
Powell
GluN2A; GluN2B; NMDA; Neuroligin 1; autism spectrum disorders; mEPSC; medium spiny neuron (MSN); synaptic transmission